← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 4, 2018Last known activity
Jun 13, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05959850Overall official - principal investigatorPhase 2Jun 13, 2023
- NCT05959850OfficialPhase 2Jun 13, 2023
- NCT03998319Study chairPhase 3Sep 4, 2018
Details
- Last known activity
- Jun 13, 2023